Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Jan;60(1):1–3. doi: 10.1136/ard.60.1.1

How to treat women with antiphospholipid antibodies in pregnancy?

R DERKSEN 1, P G DE GROOT 1, H NIEUWENHUIS 1, G CHRISTIAENS 1
PMCID: PMC1753366  PMID: 11114272

Full Text

The Full Text of this article is available as a PDF (104.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  2. Balasch J., Carmona F., López-Soto A., Font J., Creus M., Fábregues F., Ingelmo M., Vanrell J. A. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod. 1993 Dec;8(12):2234–2239. doi: 10.1093/oxfordjournals.humrep.a138009. [DOI] [PubMed] [Google Scholar]
  3. Branch D. W. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. J Reprod Immunol. 1998 Apr;38(1):75–87. doi: 10.1016/s0165-0378(98)00003-5. [DOI] [PubMed] [Google Scholar]
  4. Branch D. W., Peaceman A. M., Druzin M., Silver R. K., El-Sayed Y., Silver R. M., Esplin M. S., Spinnato J., Harger J. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):122–127. doi: 10.1016/s0002-9378(00)70500-x. [DOI] [PubMed] [Google Scholar]
  5. Branch D. W., Silver R. M., Blackwell J. L., Reading J. C., Scott J. R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992 Oct;80(4):614–620. [PubMed] [Google Scholar]
  6. Branch D. W., Silver R. M. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus. 1996 Oct;5(5):409–413. doi: 10.1177/096120339600500515. [DOI] [PubMed] [Google Scholar]
  7. Brandt J. T., Triplett D. A., Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 Oct;74(4):1185–1190. [PubMed] [Google Scholar]
  8. Cowchock F. S., Reece E. A., Balaban D., Branch D. W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992 May;166(5):1318–1323. doi: 10.1016/0002-9378(92)91596-3. [DOI] [PubMed] [Google Scholar]
  9. Harris E. N. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol. 1990 Oct;94(4):476–484. doi: 10.1093/ajcp/94.4.476. [DOI] [PubMed] [Google Scholar]
  10. Hunt B. J., Doughty H. A., Majumdar G., Copplestone A., Kerslake S., Buchanan N., Hughes G., Khamashta M. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost. 1997 Jan;77(1):39–43. [PubMed] [Google Scholar]
  11. Ichikawa K., Tsutsumi A., Atsumi T., Matsuura E., Kobayashi S., Hughes G. R., Khamashta M. A., Koike T. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 1999 Nov;42(11):2461–2470. doi: 10.1002/1529-0131(199911)42:11<2461::AID-ANR25>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  12. Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Apr 13;332(15):993–997. doi: 10.1056/NEJM199504133321504. [DOI] [PubMed] [Google Scholar]
  13. Kittner S. J., Stern B. J., Feeser B. R., Hebel R., Nagey D. A., Buchholz D. W., Earley C. J., Johnson C. J., Macko R. F., Sloan M. A. Pregnancy and the risk of stroke. N Engl J Med. 1996 Sep 12;335(11):768–774. doi: 10.1056/NEJM199609123351102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kutteh W. H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996 May;174(5):1584–1589. doi: 10.1016/s0002-9378(96)70610-5. [DOI] [PubMed] [Google Scholar]
  15. Lima F., Khamashta M. A., Buchanan N. M., Kerslake S., Hunt B. J., Hughes G. R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 1996 Mar-Apr;14(2):131–136. [PubMed] [Google Scholar]
  16. Love P. E., Santoro S. A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. doi: 10.7326/0003-4819-112-9-682. [DOI] [PubMed] [Google Scholar]
  17. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  18. Lynch A., Marlar R., Murphy J., Davila G., Santos M., Rutledge J., Emlen W. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med. 1994 Mar 15;120(6):470–475. doi: 10.7326/0003-4819-120-6-199403150-00004. [DOI] [PubMed] [Google Scholar]
  19. Out H. J., Kooijman C. D., Bruinse H. W., Derksen R. H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol. 1991 Oct 8;41(3):179–186. doi: 10.1016/0028-2243(91)90021-c. [DOI] [PubMed] [Google Scholar]
  20. Peaceman A. M., Silver R. K., MacGregor S. N., Socol M. L. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1780–1787. doi: 10.1016/0002-9378(92)91569-v. [DOI] [PubMed] [Google Scholar]
  21. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am. 1997 Jan;81(1):151–177. doi: 10.1016/s0025-7125(05)70509-5. [DOI] [PubMed] [Google Scholar]
  22. Radway-Bright E. L., Inanc M., Isenberg D. A. Animal models of the antiphospholipid syndrome. Rheumatology (Oxford) 1999 Jul;38(7):591–601. doi: 10.1093/rheumatology/38.7.591. [DOI] [PubMed] [Google Scholar]
  23. Rai R. S., Clifford K., Cohen H., Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995 Dec;10(12):3301–3304. doi: 10.1093/oxfordjournals.humrep.a135907. [DOI] [PubMed] [Google Scholar]
  24. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ. 1997 Jan 25;314(7076):253–257. doi: 10.1136/bmj.314.7076.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rand J. H., Wu X. X., Andree H. A., Lockwood C. J., Guller S., Scher J., Harpel P. C. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. N Engl J Med. 1997 Jul 17;337(3):154–160. doi: 10.1056/NEJM199707173370303. [DOI] [PubMed] [Google Scholar]
  26. Reber G., Arvieux J., Comby E., Degenne D., de Moerloose P., Sanmarco M., Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose). Thromb Haemost. 1995 Mar;73(3):444–452. [PubMed] [Google Scholar]
  27. Rosendaal F. R. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost. 1997 Jul;78(1):1–6. [PubMed] [Google Scholar]
  28. Roubey R. A. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996 Sep;39(9):1444–1454. doi: 10.1002/art.1780390903. [DOI] [PubMed] [Google Scholar]
  29. Sanson B. J., Lensing A. W., Prins M. H., Ginsberg J. S., Barkagan Z. S., Lavenne-Pardonge E., Brenner B., Dulitzky M., Nielsen J. D., Boda Z. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999 May;81(5):668–672. [PubMed] [Google Scholar]
  30. Triplett D. A. Many faces of lupus anticoagulants. Lupus. 1998;7 (Suppl 2):S18–S22. doi: 10.1177/096120339800700205. [DOI] [PubMed] [Google Scholar]
  31. Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., Brey R., Derksen R., Harris E. N., Hughes G. R. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  32. van Leeuwen I., Branch D. W., Scott J. R. First-trimester ultrasonography findings in women with a history of recurrent pregnancy loss. Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):111–114. doi: 10.1016/s0002-9378(12)90896-0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES